nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ABCB1—esophageal cancer	0.719	1	CbGaD
Cilazapril—ACE—thoracic aorta—esophageal cancer	0.0628	0.59	CbGeAlD
Cilazapril—ACE—neck—esophageal cancer	0.00554	0.052	CbGeAlD
Cilazapril—SLC15A1—epithelium—esophageal cancer	0.00525	0.0494	CbGeAlD
Cilazapril—SLC15A1—digestive system—esophageal cancer	0.004	0.0376	CbGeAlD
Cilazapril—ACE—epithelium—esophageal cancer	0.00377	0.0354	CbGeAlD
Cilazapril—ACE—smooth muscle tissue—esophageal cancer	0.00363	0.0341	CbGeAlD
Cilazapril—SLC15A2—bronchus—esophageal cancer	0.00324	0.0304	CbGeAlD
Cilazapril—SLC15A2—trachea—esophageal cancer	0.0029	0.0273	CbGeAlD
Cilazapril—ACE—digestive system—esophageal cancer	0.00287	0.0269	CbGeAlD
Cilazapril—ACE—lung—esophageal cancer	0.00239	0.0225	CbGeAlD
Cilazapril—SLC15A2—lung—esophageal cancer	0.00209	0.0196	CbGeAlD
Cilazapril—ACE—lymph node—esophageal cancer	0.00164	0.0154	CbGeAlD
Cilazapril—Rash erythematous—Capecitabine—esophageal cancer	0.00162	0.00941	CcSEcCtD
Cilazapril—Myocardial ischaemia—Capecitabine—esophageal cancer	0.00154	0.00897	CcSEcCtD
Cilazapril—Rigors—Capecitabine—esophageal cancer	0.00152	0.00883	CcSEcCtD
Cilazapril—Dysphonia—Capecitabine—esophageal cancer	0.00151	0.00876	CcSEcCtD
Cilazapril—Extrasystoles—Capecitabine—esophageal cancer	0.00147	0.00857	CcSEcCtD
Cilazapril—SLC15A2—lymph node—esophageal cancer	0.00143	0.0134	CbGeAlD
Cilazapril—Proteinuria—Capecitabine—esophageal cancer	0.00141	0.0082	CcSEcCtD
Cilazapril—Protein urine present—Capecitabine—esophageal cancer	0.00139	0.00809	CcSEcCtD
Cilazapril—Polyuria—Cisplatin—esophageal cancer	0.00139	0.00808	CcSEcCtD
Cilazapril—Rectal haemorrhage—Capecitabine—esophageal cancer	0.00137	0.00798	CcSEcCtD
Cilazapril—Haemolytic anaemia—Cisplatin—esophageal cancer	0.00135	0.00786	CcSEcCtD
Cilazapril—Cardiac failure congestive—Cisplatin—esophageal cancer	0.00135	0.00783	CcSEcCtD
Cilazapril—ABCB1—epithelium—esophageal cancer	0.00133	0.0125	CbGeAlD
Cilazapril—Renal failure acute—Cisplatin—esophageal cancer	0.00132	0.00769	CcSEcCtD
Cilazapril—Cerebrovascular accident—Cisplatin—esophageal cancer	0.00125	0.00724	CcSEcCtD
Cilazapril—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.00122	0.0071	CcSEcCtD
Cilazapril—Face oedema—Cisplatin—esophageal cancer	0.00118	0.00685	CcSEcCtD
Cilazapril—Necrosis—Methotrexate—esophageal cancer	0.00118	0.00684	CcSEcCtD
Cilazapril—ABCB1—trachea—esophageal cancer	0.00117	0.011	CbGeAlD
Cilazapril—Urine output increased—Capecitabine—esophageal cancer	0.00112	0.00652	CcSEcCtD
Cilazapril—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00112	0.00648	CcSEcCtD
Cilazapril—Abnormal vision—Capecitabine—esophageal cancer	0.00108	0.00629	CcSEcCtD
Cilazapril—Proteinuria—Methotrexate—esophageal cancer	0.00105	0.00611	CcSEcCtD
Cilazapril—Protein urine present—Methotrexate—esophageal cancer	0.00104	0.00602	CcSEcCtD
Cilazapril—Pancreatitis—Cisplatin—esophageal cancer	0.00104	0.00601	CcSEcCtD
Cilazapril—Hepatic function abnormal—Capecitabine—esophageal cancer	0.00103	0.00599	CcSEcCtD
Cilazapril—Sweating increased—Cisplatin—esophageal cancer	0.00103	0.00598	CcSEcCtD
Cilazapril—Photosensitivity—Capecitabine—esophageal cancer	0.00103	0.00596	CcSEcCtD
Cilazapril—Polyuria—Capecitabine—esophageal cancer	0.00103	0.00596	CcSEcCtD
Cilazapril—ABCB1—digestive system—esophageal cancer	0.00101	0.00948	CbGeAlD
Cilazapril—Vascular purpura—Capecitabine—esophageal cancer	0.00101	0.00585	CcSEcCtD
Cilazapril—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000998	0.0058	CcSEcCtD
Cilazapril—Renal failure acute—Capecitabine—esophageal cancer	0.000976	0.00567	CcSEcCtD
Cilazapril—Libido decreased—Capecitabine—esophageal cancer	0.000971	0.00564	CcSEcCtD
Cilazapril—Hot flush—Capecitabine—esophageal cancer	0.000963	0.00559	CcSEcCtD
Cilazapril—Menopausal symptoms—Capecitabine—esophageal cancer	0.000955	0.00554	CcSEcCtD
Cilazapril—Atrial fibrillation—Capecitabine—esophageal cancer	0.00095	0.00552	CcSEcCtD
Cilazapril—Renal impairment—Capecitabine—esophageal cancer	0.000946	0.0055	CcSEcCtD
Cilazapril—Purpura—Capecitabine—esophageal cancer	0.000935	0.00543	CcSEcCtD
Cilazapril—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000928	0.00539	CcSEcCtD
Cilazapril—Renal failure—Cisplatin—esophageal cancer	0.000926	0.00538	CcSEcCtD
Cilazapril—Myocardial infarction—Cisplatin—esophageal cancer	0.000923	0.00536	CcSEcCtD
Cilazapril—Cardiac failure—Capecitabine—esophageal cancer	0.000923	0.00536	CcSEcCtD
Cilazapril—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000919	0.00534	CcSEcCtD
Cilazapril—Conjunctivitis—Cisplatin—esophageal cancer	0.000915	0.00532	CcSEcCtD
Cilazapril—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000901	0.00523	CcSEcCtD
Cilazapril—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000894	0.00519	CcSEcCtD
Cilazapril—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000891	0.00517	CcSEcCtD
Cilazapril—Migraine—Capecitabine—esophageal cancer	0.000887	0.00515	CcSEcCtD
Cilazapril—Face oedema—Capecitabine—esophageal cancer	0.00087	0.00505	CcSEcCtD
Cilazapril—Bradycardia—Cisplatin—esophageal cancer	0.000861	0.005	CcSEcCtD
Cilazapril—Ataxia—Capecitabine—esophageal cancer	0.000847	0.00492	CcSEcCtD
Cilazapril—ABCB1—lung—esophageal cancer	0.000843	0.00792	CbGeAlD
Cilazapril—Urine output increased—Methotrexate—esophageal cancer	0.000835	0.00485	CcSEcCtD
Cilazapril—Urinary tract disorder—Cisplatin—esophageal cancer	0.000835	0.00485	CcSEcCtD
Cilazapril—Liver function test abnormal—Capecitabine—esophageal cancer	0.000832	0.00483	CcSEcCtD
Cilazapril—Urethral disorder—Cisplatin—esophageal cancer	0.000829	0.00481	CcSEcCtD
Cilazapril—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000823	0.00478	CcSEcCtD
Cilazapril—Visual impairment—Cisplatin—esophageal cancer	0.000815	0.00473	CcSEcCtD
Cilazapril—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000811	0.00471	CcSEcCtD
Cilazapril—Tinnitus—Cisplatin—esophageal cancer	0.000788	0.00458	CcSEcCtD
Cilazapril—Flushing—Cisplatin—esophageal cancer	0.000785	0.00456	CcSEcCtD
Cilazapril—Cardiac disorder—Cisplatin—esophageal cancer	0.000785	0.00456	CcSEcCtD
Cilazapril—Bronchospasm—Capecitabine—esophageal cancer	0.000766	0.00445	CcSEcCtD
Cilazapril—Photosensitivity—Methotrexate—esophageal cancer	0.000764	0.00444	CcSEcCtD
Cilazapril—Polyuria—Methotrexate—esophageal cancer	0.000764	0.00444	CcSEcCtD
Cilazapril—Immune system disorder—Cisplatin—esophageal cancer	0.000764	0.00443	CcSEcCtD
Cilazapril—Sweating increased—Capecitabine—esophageal cancer	0.000758	0.0044	CcSEcCtD
Cilazapril—Angina pectoris—Capecitabine—esophageal cancer	0.000758	0.0044	CcSEcCtD
Cilazapril—Arrhythmia—Cisplatin—esophageal cancer	0.000755	0.00439	CcSEcCtD
Cilazapril—Bronchitis—Capecitabine—esophageal cancer	0.000749	0.00435	CcSEcCtD
Cilazapril—Alopecia—Cisplatin—esophageal cancer	0.000747	0.00434	CcSEcCtD
Cilazapril—Neutropenia—Capecitabine—esophageal cancer	0.000728	0.00423	CcSEcCtD
Cilazapril—Dysuria—Capecitabine—esophageal cancer	0.000728	0.00423	CcSEcCtD
Cilazapril—Renal failure acute—Methotrexate—esophageal cancer	0.000726	0.00422	CcSEcCtD
Cilazapril—Flatulence—Cisplatin—esophageal cancer	0.000725	0.00421	CcSEcCtD
Cilazapril—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000711	0.00413	CcSEcCtD
Cilazapril—Muscle spasms—Cisplatin—esophageal cancer	0.000707	0.00411	CcSEcCtD
Cilazapril—Hyperglycaemia—Capecitabine—esophageal cancer	0.000702	0.00408	CcSEcCtD
Cilazapril—Tremor—Cisplatin—esophageal cancer	0.000689	0.004	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000688	0.004	CcSEcCtD
Cilazapril—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000684	0.00397	CcSEcCtD
Cilazapril—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000684	0.00397	CcSEcCtD
Cilazapril—Ill-defined disorder—Cisplatin—esophageal cancer	0.000683	0.00397	CcSEcCtD
Cilazapril—Renal failure—Capecitabine—esophageal cancer	0.000682	0.00396	CcSEcCtD
Cilazapril—Myocardial infarction—Capecitabine—esophageal cancer	0.00068	0.00395	CcSEcCtD
Cilazapril—Anaemia—Cisplatin—esophageal cancer	0.00068	0.00395	CcSEcCtD
Cilazapril—Conjunctivitis—Capecitabine—esophageal cancer	0.000675	0.00392	CcSEcCtD
Cilazapril—Malaise—Cisplatin—esophageal cancer	0.000664	0.00385	CcSEcCtD
Cilazapril—Leukopenia—Cisplatin—esophageal cancer	0.000659	0.00383	CcSEcCtD
Cilazapril—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000656	0.00381	CcSEcCtD
Cilazapril—Epistaxis—Capecitabine—esophageal cancer	0.000655	0.0038	CcSEcCtD
Cilazapril—Agranulocytosis—Capecitabine—esophageal cancer	0.000648	0.00376	CcSEcCtD
Cilazapril—Bradycardia—Capecitabine—esophageal cancer	0.000634	0.00368	CcSEcCtD
Cilazapril—Perindopril—ABCB1—esophageal cancer	0.000632	0.291	CrCbGaD
Cilazapril—Ataxia—Methotrexate—esophageal cancer	0.00063	0.00366	CcSEcCtD
Cilazapril—Myalgia—Cisplatin—esophageal cancer	0.000626	0.00364	CcSEcCtD
Cilazapril—Rhinitis—Capecitabine—esophageal cancer	0.000625	0.00363	CcSEcCtD
Cilazapril—Anxiety—Cisplatin—esophageal cancer	0.000624	0.00363	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000622	0.00361	CcSEcCtD
Cilazapril—Hypoaesthesia—Capecitabine—esophageal cancer	0.00062	0.0036	CcSEcCtD
Cilazapril—Liver function test abnormal—Methotrexate—esophageal cancer	0.000619	0.0036	CcSEcCtD
Cilazapril—Discomfort—Cisplatin—esophageal cancer	0.000619	0.0036	CcSEcCtD
Cilazapril—Pharyngitis—Capecitabine—esophageal cancer	0.000618	0.00359	CcSEcCtD
Cilazapril—Urinary tract disorder—Capecitabine—esophageal cancer	0.000615	0.00357	CcSEcCtD
Cilazapril—Urethral disorder—Capecitabine—esophageal cancer	0.000611	0.00355	CcSEcCtD
Cilazapril—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000604	0.00351	CcSEcCtD
Cilazapril—Oedema—Cisplatin—esophageal cancer	0.000601	0.00349	CcSEcCtD
Cilazapril—Visual impairment—Capecitabine—esophageal cancer	0.0006	0.00349	CcSEcCtD
Cilazapril—Erythema multiforme—Capecitabine—esophageal cancer	0.000589	0.00342	CcSEcCtD
Cilazapril—Thrombocytopenia—Cisplatin—esophageal cancer	0.000588	0.00342	CcSEcCtD
Cilazapril—Tachycardia—Cisplatin—esophageal cancer	0.000586	0.0034	CcSEcCtD
Cilazapril—Skin disorder—Cisplatin—esophageal cancer	0.000583	0.00339	CcSEcCtD
Cilazapril—Tinnitus—Capecitabine—esophageal cancer	0.000581	0.00337	CcSEcCtD
Cilazapril—Hyperhidrosis—Cisplatin—esophageal cancer	0.000581	0.00337	CcSEcCtD
Cilazapril—Flushing—Capecitabine—esophageal cancer	0.000578	0.00336	CcSEcCtD
Cilazapril—Cardiac disorder—Capecitabine—esophageal cancer	0.000578	0.00336	CcSEcCtD
Cilazapril—ABCB1—lymph node—esophageal cancer	0.000576	0.00541	CbGeAlD
Cilazapril—Nateglinide—PTGS1—esophageal cancer	0.000574	0.264	CrCbGaD
Cilazapril—Anorexia—Cisplatin—esophageal cancer	0.000572	0.00333	CcSEcCtD
Cilazapril—Pancreatitis—Methotrexate—esophageal cancer	0.000568	0.0033	CcSEcCtD
Cilazapril—Angiopathy—Capecitabine—esophageal cancer	0.000565	0.00328	CcSEcCtD
Cilazapril—Immune system disorder—Capecitabine—esophageal cancer	0.000563	0.00327	CcSEcCtD
Cilazapril—Hypotension—Cisplatin—esophageal cancer	0.000561	0.00326	CcSEcCtD
Cilazapril—Chills—Capecitabine—esophageal cancer	0.000559	0.00325	CcSEcCtD
Cilazapril—Lisinopril—ABCB1—esophageal cancer	0.000557	0.256	CrCbGaD
Cilazapril—Arrhythmia—Capecitabine—esophageal cancer	0.000557	0.00323	CcSEcCtD
Cilazapril—Alopecia—Capecitabine—esophageal cancer	0.000551	0.0032	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000547	0.00318	CcSEcCtD
Cilazapril—Dysuria—Methotrexate—esophageal cancer	0.000542	0.00315	CcSEcCtD
Cilazapril—Neutropenia—Methotrexate—esophageal cancer	0.000542	0.00315	CcSEcCtD
Cilazapril—Paraesthesia—Cisplatin—esophageal cancer	0.000539	0.00313	CcSEcCtD
Cilazapril—Dyspnoea—Cisplatin—esophageal cancer	0.000535	0.00311	CcSEcCtD
Cilazapril—Flatulence—Capecitabine—esophageal cancer	0.000534	0.0031	CcSEcCtD
Cilazapril—Erectile dysfunction—Methotrexate—esophageal cancer	0.000534	0.0031	CcSEcCtD
Cilazapril—Dysgeusia—Capecitabine—esophageal cancer	0.000531	0.00309	CcSEcCtD
Cilazapril—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000529	0.00307	CcSEcCtD
Cilazapril—Decreased appetite—Cisplatin—esophageal cancer	0.000522	0.00303	CcSEcCtD
Cilazapril—Muscle spasms—Capecitabine—esophageal cancer	0.000521	0.00303	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000518	0.00301	CcSEcCtD
Cilazapril—Pain—Cisplatin—esophageal cancer	0.000514	0.00298	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000512	0.00298	CcSEcCtD
Cilazapril—Tremor—Capecitabine—esophageal cancer	0.000508	0.00295	CcSEcCtD
Cilazapril—Renal failure—Methotrexate—esophageal cancer	0.000508	0.00295	CcSEcCtD
Cilazapril—Ill-defined disorder—Capecitabine—esophageal cancer	0.000503	0.00292	CcSEcCtD
Cilazapril—Conjunctivitis—Methotrexate—esophageal cancer	0.000502	0.00292	CcSEcCtD
Cilazapril—Anaemia—Capecitabine—esophageal cancer	0.000501	0.00291	CcSEcCtD
Cilazapril—Feeling abnormal—Cisplatin—esophageal cancer	0.000495	0.00287	CcSEcCtD
Cilazapril—Malaise—Capecitabine—esophageal cancer	0.000489	0.00284	CcSEcCtD
Cilazapril—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000489	0.00284	CcSEcCtD
Cilazapril—Epistaxis—Methotrexate—esophageal cancer	0.000487	0.00283	CcSEcCtD
Cilazapril—Vertigo—Capecitabine—esophageal cancer	0.000487	0.00283	CcSEcCtD
Cilazapril—Syncope—Capecitabine—esophageal cancer	0.000486	0.00283	CcSEcCtD
Cilazapril—Leukopenia—Capecitabine—esophageal cancer	0.000486	0.00282	CcSEcCtD
Cilazapril—Agranulocytosis—Methotrexate—esophageal cancer	0.000482	0.0028	CcSEcCtD
Cilazapril—Palpitations—Capecitabine—esophageal cancer	0.000479	0.00278	CcSEcCtD
Cilazapril—Loss of consciousness—Capecitabine—esophageal cancer	0.000477	0.00277	CcSEcCtD
Cilazapril—Cough—Capecitabine—esophageal cancer	0.000473	0.00275	CcSEcCtD
Cilazapril—Hypertension—Capecitabine—esophageal cancer	0.000468	0.00272	CcSEcCtD
Cilazapril—Myalgia—Capecitabine—esophageal cancer	0.000462	0.00268	CcSEcCtD
Cilazapril—Arthralgia—Capecitabine—esophageal cancer	0.000462	0.00268	CcSEcCtD
Cilazapril—Chest pain—Capecitabine—esophageal cancer	0.000462	0.00268	CcSEcCtD
Cilazapril—Pharyngitis—Methotrexate—esophageal cancer	0.00046	0.00267	CcSEcCtD
Cilazapril—Anxiety—Capecitabine—esophageal cancer	0.00046	0.00267	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000459	0.00266	CcSEcCtD
Cilazapril—Urinary tract disorder—Methotrexate—esophageal cancer	0.000458	0.00266	CcSEcCtD
Cilazapril—Discomfort—Capecitabine—esophageal cancer	0.000456	0.00265	CcSEcCtD
Cilazapril—Urethral disorder—Methotrexate—esophageal cancer	0.000455	0.00264	CcSEcCtD
Cilazapril—Dry mouth—Capecitabine—esophageal cancer	0.000452	0.00262	CcSEcCtD
Cilazapril—Visual impairment—Methotrexate—esophageal cancer	0.000447	0.0026	CcSEcCtD
Cilazapril—Confusional state—Capecitabine—esophageal cancer	0.000446	0.00259	CcSEcCtD
Cilazapril—Oedema—Capecitabine—esophageal cancer	0.000443	0.00257	CcSEcCtD
Cilazapril—Hypersensitivity—Cisplatin—esophageal cancer	0.000442	0.00257	CcSEcCtD
Cilazapril—Erythema multiforme—Methotrexate—esophageal cancer	0.000439	0.00255	CcSEcCtD
Cilazapril—Shock—Capecitabine—esophageal cancer	0.000436	0.00253	CcSEcCtD
Cilazapril—Thrombocytopenia—Capecitabine—esophageal cancer	0.000433	0.00252	CcSEcCtD
Cilazapril—Tinnitus—Methotrexate—esophageal cancer	0.000432	0.00251	CcSEcCtD
Cilazapril—Tachycardia—Capecitabine—esophageal cancer	0.000432	0.00251	CcSEcCtD
Cilazapril—Asthenia—Cisplatin—esophageal cancer	0.000431	0.0025	CcSEcCtD
Cilazapril—Cardiac disorder—Methotrexate—esophageal cancer	0.00043	0.0025	CcSEcCtD
Cilazapril—Skin disorder—Capecitabine—esophageal cancer	0.00043	0.0025	CcSEcCtD
Cilazapril—Hyperhidrosis—Capecitabine—esophageal cancer	0.000428	0.00249	CcSEcCtD
Cilazapril—Anorexia—Capecitabine—esophageal cancer	0.000422	0.00245	CcSEcCtD
Cilazapril—Angiopathy—Methotrexate—esophageal cancer	0.000421	0.00244	CcSEcCtD
Cilazapril—Immune system disorder—Methotrexate—esophageal cancer	0.000419	0.00243	CcSEcCtD
Cilazapril—Chills—Methotrexate—esophageal cancer	0.000416	0.00242	CcSEcCtD
Cilazapril—Hypotension—Capecitabine—esophageal cancer	0.000414	0.0024	CcSEcCtD
Cilazapril—Diarrhoea—Cisplatin—esophageal cancer	0.000411	0.00239	CcSEcCtD
Cilazapril—Alopecia—Methotrexate—esophageal cancer	0.00041	0.00238	CcSEcCtD
Cilazapril—Enalapril—ABCB1—esophageal cancer	0.000409	0.188	CrCbGaD
Cilazapril—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000403	0.00234	CcSEcCtD
Cilazapril—Insomnia—Capecitabine—esophageal cancer	0.0004	0.00233	CcSEcCtD
Cilazapril—Paraesthesia—Capecitabine—esophageal cancer	0.000398	0.00231	CcSEcCtD
Cilazapril—Dysgeusia—Methotrexate—esophageal cancer	0.000395	0.0023	CcSEcCtD
Cilazapril—Dyspnoea—Capecitabine—esophageal cancer	0.000395	0.00229	CcSEcCtD
Cilazapril—Dyspepsia—Capecitabine—esophageal cancer	0.00039	0.00226	CcSEcCtD
Cilazapril—Decreased appetite—Capecitabine—esophageal cancer	0.000385	0.00224	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000382	0.00222	CcSEcCtD
Cilazapril—Vomiting—Cisplatin—esophageal cancer	0.000382	0.00222	CcSEcCtD
Cilazapril—Fatigue—Capecitabine—esophageal cancer	0.000382	0.00222	CcSEcCtD
Cilazapril—Rash—Cisplatin—esophageal cancer	0.000379	0.0022	CcSEcCtD
Cilazapril—Pain—Capecitabine—esophageal cancer	0.000379	0.0022	CcSEcCtD
Cilazapril—Constipation—Capecitabine—esophageal cancer	0.000379	0.0022	CcSEcCtD
Cilazapril—Dermatitis—Cisplatin—esophageal cancer	0.000378	0.0022	CcSEcCtD
Cilazapril—Ill-defined disorder—Methotrexate—esophageal cancer	0.000375	0.00218	CcSEcCtD
Cilazapril—Anaemia—Methotrexate—esophageal cancer	0.000373	0.00217	CcSEcCtD
Cilazapril—Feeling abnormal—Capecitabine—esophageal cancer	0.000365	0.00212	CcSEcCtD
Cilazapril—Malaise—Methotrexate—esophageal cancer	0.000364	0.00212	CcSEcCtD
Cilazapril—Vertigo—Methotrexate—esophageal cancer	0.000363	0.00211	CcSEcCtD
Cilazapril—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000362	0.0021	CcSEcCtD
Cilazapril—Leukopenia—Methotrexate—esophageal cancer	0.000361	0.0021	CcSEcCtD
Cilazapril—Nausea—Cisplatin—esophageal cancer	0.000357	0.00207	CcSEcCtD
Cilazapril—Cough—Methotrexate—esophageal cancer	0.000352	0.00205	CcSEcCtD
Cilazapril—Urticaria—Capecitabine—esophageal cancer	0.000352	0.00204	CcSEcCtD
Cilazapril—Abdominal pain—Capecitabine—esophageal cancer	0.00035	0.00203	CcSEcCtD
Cilazapril—Arthralgia—Methotrexate—esophageal cancer	0.000344	0.002	CcSEcCtD
Cilazapril—Chest pain—Methotrexate—esophageal cancer	0.000344	0.002	CcSEcCtD
Cilazapril—Myalgia—Methotrexate—esophageal cancer	0.000344	0.002	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000341	0.00198	CcSEcCtD
Cilazapril—Discomfort—Methotrexate—esophageal cancer	0.00034	0.00197	CcSEcCtD
Cilazapril—Confusional state—Methotrexate—esophageal cancer	0.000332	0.00193	CcSEcCtD
Cilazapril—Hypersensitivity—Capecitabine—esophageal cancer	0.000326	0.00189	CcSEcCtD
Cilazapril—Thrombocytopenia—Methotrexate—esophageal cancer	0.000323	0.00187	CcSEcCtD
Cilazapril—Skin disorder—Methotrexate—esophageal cancer	0.00032	0.00186	CcSEcCtD
Cilazapril—Hyperhidrosis—Methotrexate—esophageal cancer	0.000319	0.00185	CcSEcCtD
Cilazapril—Asthenia—Capecitabine—esophageal cancer	0.000318	0.00184	CcSEcCtD
Cilazapril—Anorexia—Methotrexate—esophageal cancer	0.000314	0.00182	CcSEcCtD
Cilazapril—Pruritus—Capecitabine—esophageal cancer	0.000313	0.00182	CcSEcCtD
Cilazapril—Hypotension—Methotrexate—esophageal cancer	0.000308	0.00179	CcSEcCtD
Cilazapril—Diarrhoea—Capecitabine—esophageal cancer	0.000303	0.00176	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.0003	0.00174	CcSEcCtD
Cilazapril—Insomnia—Methotrexate—esophageal cancer	0.000298	0.00173	CcSEcCtD
Cilazapril—Paraesthesia—Methotrexate—esophageal cancer	0.000296	0.00172	CcSEcCtD
Cilazapril—Dyspnoea—Methotrexate—esophageal cancer	0.000294	0.00171	CcSEcCtD
Cilazapril—Somnolence—Methotrexate—esophageal cancer	0.000293	0.0017	CcSEcCtD
Cilazapril—Dizziness—Capecitabine—esophageal cancer	0.000293	0.0017	CcSEcCtD
Cilazapril—Dyspepsia—Methotrexate—esophageal cancer	0.00029	0.00168	CcSEcCtD
Cilazapril—Decreased appetite—Methotrexate—esophageal cancer	0.000286	0.00166	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000285	0.00165	CcSEcCtD
Cilazapril—Fatigue—Methotrexate—esophageal cancer	0.000284	0.00165	CcSEcCtD
Cilazapril—Pain—Methotrexate—esophageal cancer	0.000282	0.00164	CcSEcCtD
Cilazapril—Vomiting—Capecitabine—esophageal cancer	0.000281	0.00163	CcSEcCtD
Cilazapril—Rash—Capecitabine—esophageal cancer	0.000279	0.00162	CcSEcCtD
Cilazapril—Dermatitis—Capecitabine—esophageal cancer	0.000279	0.00162	CcSEcCtD
Cilazapril—Headache—Capecitabine—esophageal cancer	0.000277	0.00161	CcSEcCtD
Cilazapril—Feeling abnormal—Methotrexate—esophageal cancer	0.000272	0.00158	CcSEcCtD
Cilazapril—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000269	0.00157	CcSEcCtD
Cilazapril—Nausea—Capecitabine—esophageal cancer	0.000263	0.00153	CcSEcCtD
Cilazapril—Urticaria—Methotrexate—esophageal cancer	0.000262	0.00152	CcSEcCtD
Cilazapril—Abdominal pain—Methotrexate—esophageal cancer	0.000261	0.00151	CcSEcCtD
Cilazapril—Hypersensitivity—Methotrexate—esophageal cancer	0.000243	0.00141	CcSEcCtD
Cilazapril—Asthenia—Methotrexate—esophageal cancer	0.000236	0.00137	CcSEcCtD
Cilazapril—Pruritus—Methotrexate—esophageal cancer	0.000233	0.00135	CcSEcCtD
Cilazapril—Diarrhoea—Methotrexate—esophageal cancer	0.000225	0.00131	CcSEcCtD
Cilazapril—Dizziness—Methotrexate—esophageal cancer	0.000218	0.00127	CcSEcCtD
Cilazapril—Vomiting—Methotrexate—esophageal cancer	0.00021	0.00122	CcSEcCtD
Cilazapril—Rash—Methotrexate—esophageal cancer	0.000208	0.00121	CcSEcCtD
Cilazapril—Dermatitis—Methotrexate—esophageal cancer	0.000208	0.00121	CcSEcCtD
Cilazapril—Headache—Methotrexate—esophageal cancer	0.000206	0.0012	CcSEcCtD
Cilazapril—Nausea—Methotrexate—esophageal cancer	0.000196	0.00114	CcSEcCtD
